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BACKGROUND: Exposure to ionising radiation is a well-established risk factor for multiple types of tumours, including malignant brain
tumours. In the 1950s, radiotherapy was used to treat Tinea Capitis (TC) in thousands of children, mostly of North-African and
Middle Eastern origin, during the mass migration to Israel. The over-representation of radiation-associated meningioma (RAM)
and other cancers in specific families provide support for inherited genetic susceptibility to radiation-induced cancer.
METHODS: To test this hypothesis, we genotyped 15 families segregating RAM using high-density single-nucleotide polymorphism
(SNP) arrays. Using the family-based association test (FBAT) programme, we tested each polymorphism and haplotype for
an association with RAM.
RESULTS: The strongest haplotype associations were attained at 18q21.1 (P¼7.5 10
 5), 18q21.31 (P¼2.8 10
 5) and 10q21.3
(P¼1.6 10
 4). Although associations were not formally statistically significant after adjustment for multiple testing, the 18q21.1 and
10q21.3 associations provide support for a variation in PIAS2, KATNAL2, TCEB3C, TCEB3CL and CTNNA3 genes as risk factors
for RAM.
CONCLUSION: These findings suggest that any underlying genetic susceptibility to RAM is likely to be mediated through the
co-inheritance of multiple risk alleles rather than a single major gene locus determining radiosensitivity.
British Journal of Cancer (2011) 104, 1049–1054. doi:10.1038/bjc.2011.61 www.bjcancer.com
Published online 1 March 2011
& 2011 Cancer Research UK
Keywords: ionising radiation; meningioma; genetic; sensitivity
                                                   
A number of rare inherited cancer syndromes are typified by
radiosensitivity, such as Gorlin and Li-Fraumeni syndromes (Gatti,
2001). Collectively, these diseases are, however, rare. Evidence that
inherited sensitivity to radiation may have a more general genetic
basis is provided by the observation that cancer patients and
some of their first-degree relatives exhibit increased in vitro
radiosensitivity compared with healthy controls (Roberts et al,
1999; Burrill et al, 2000).
Ionising radiation is the only environmental factor that has been
shown unequivocally to be a causative factor for meningioma
development (Sadetzki et al, 2005a; Bondy et al, 2008). During the
mass migration to Israel in the 1950s, the Israeli authorities
undertook a wide-scale campaign to eradicate Tinea Capitis (TC).
The treatment included radiotherapy to the head area and was
administered to children with TC in Israel and abroad, mainly in
North-African and Middle Eastern countries, who were planning to
immigrate to Israel. The therapeutic procedure followed the
Adamson-Kienbock technique. The hair had been shaved and
any remaining hair was removed through a waxing process.
Subsequently, the scalp area was divided into five fields, each being
treated on one of five consecutive days. The irradiation was done
with a 75–100kV superficial therapy X-ray machine. The children
were exposed to 3.5–4.0Gy for each field, at a focus skin distance
of 25–30cm. Most individuals received one course of radiation,
but B9% of the patients received X2 treatments (Werner
et al, 1968).
A subgroup of children who were treated in Israel, including a
group of 10842 irradiated individuals with two matched non-
exposed population and sibling groups (referred henceforth as the
TC cohort), has been systematically followed for over 50 years for
radiation sequelae. Radiation dosimetry was done for this cohort
in the late 1960s using one of the original X-ray machines and a
head phantom. These studies estimated the average dose to the
brain at 1.5Gy (s.d. 0.52, range 1.0–6.0Gy). Doses were also
calculated for different areas of the brain with the lowest average
dose being for the back and front of the lower plane (mean 1.1Gy,
s.d. 0.37, range 0.71–4.30), whereas the highest dose was for the
front of the upper plane (mean 1.8Gy, s.d. 0.61, range 1.17–7.11)
(Ron et al, 1988).
Although affecting o1% of the TC cohort, a marked increase in
the risk of meningioma (ERR/Gy 4.63; 95% CI: 2.4–9.1) is one of
the most prominent observations seen among the exposed
individuals (Sadetzki et al, 2005a).
On the basis of the above-mentioned results, a law was
established in Israel in 1994, for the purpose of compensating
irradiated individuals who had developed specific diseases that
were proven to be causally associated with the irradiation given as
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streatment for TC. The irradiated and nonirradiated cases and
controls from the TC cohort, as well as irradiated cases who
claimed compensation within the framework of the law, constitute
the study population for nested case–control studies designed to
assess interaction between ionising radiation and other environ-
mental and genetic risk factors in the development of cancer
(Sadetzki et al, 2005b; Flint-Richter and Sadetzki, 2007). These
studies have demonstrated an over-representation of radiation-
associated meningioma (RAM) and other radiation-associated
cancers in specific families. This finding indicates that the
occurrence of the tumour following the exposure is not a random
event, and provides support for the hypothesis of inherited genetic
susceptibility to radiation-induced cancers (Flint-Richter and
Sadetzki, 2007).
The TC cohort is derived from a population that is characterised
by high levels of linkage disequilibrium (LD). This allelic
architecture affords enhanced power to localise and identify
disease-causing alleles through association-based analyses espe-
cially if a restricted gene set underscores inherited susceptibility to
RAM. In this study we report a search for RAM susceptibility
alleles in TC families through an LD association-based analysis
of genomewide single-nucleotide polymorphism (SNP) genotypes.
SUBJECTS AND METHODS
Subjects
Our search for alleles predisposing to RAM was based on families
ascertained through the TC studies. In total, 15 families in whom
X2 cases of RAM have been diagnosed among first-degree
relatives were identified (Table 1). Of these families, 14 were
identified from a larger epidemiological, genetic case–control
study that included 160 RAM participants of whom 17 have
reported on at least one sibling who was diagnosed with
meningioma. However, out of these families, only 14 agreed to
participate in the current study. More details on the methodology
of this study have been previously published (Sadetzki et al, 2005b;
Flint-Richter and Sadetzki, 2007). One additional family was
recruited from the claim files, resulting in a total of 15 families.
The target study population included 120 individuals (40 RAM,
14 healthy irradiated, 49 healthy nonirradiated, 9 irradiated with
other cancer and 8 nonirradiated with other cancer); the number
of siblings in each family ranged from 5 to 12. The age at diagnosis
for the RAM patients ranged from 35 to 69 years (mean 48.7±9.2).
Validation for irradiation status and for tumour pathology was
performed for all of these family members, using medical records
for pathology verification and a set of criteria that were used in
previous studies (Sadetzki et al, 2005b) for irradiation verification.
Biological specimens were collected from 71 individuals;
however, the final genetic analysis was based on 65 samples
because only DNA extracted from peripheral blood (n¼66,
27 RAM) was used and 1 DNA was excluded because of having
an overall call rate of o95% (Table 1).
Ethics
Collection of blood samples and clinicopathological information
from subjects was undertaken with informed consent and relevant
ethical review board approval in accordance with the tenets of the
Declaration of Helsinki.
Genotyping
DNA was extracted from EDTA-venous blood samples using
conventional methods and quantified using PicoGreen (Invitrogen,
Carlsbad, CA, USA). Genotyping was conducted using Illumina
610Quad arrays according to the manufacturer’s protocols
(Illumina San Diego, CA, USA). To ensure quality of genotyping,
a series of duplicate samples was genotyped, resulting in 99.99%
concordant calls. We excluded SNPs from analysis if they failed
one or more of the following thresholds: GenCall scores o0.25;
overall call rates o95%; minor allele frequency (MAF) p0.01;
outlying in terms of signal intensity or X:Y ratio; discordance
between duplicate samples; and, for SNPs with evidence of
association, and poor clustering on inspection of X:Y plots.
Statistical analyses
The primary analysis was for association of individual SNPs with
the binary trait of RAM, using the family-based association test
(FBAT) programme (Horvath et al, 2001), and for haplotypes,
using the haplotype extension (HBAT) of the FBAT programme
Table 1 Description of RAM families having two or more members with meningioma among siblings
Final population for genetic analysis
RAM Non-RAM siblings
Family
ID
Ethnic
origin
No. of
siblings
with RAM
Other
cancers in
irradiated
siblings
Other
cancers in
nonirradiated
siblings
No. of
healthy
irradiated
siblings
No. of
healthy
nonirradiated
siblings
Total no.
of
siblings
No. of
blood
samples*
No. of
siblings
with RAM
Ages at
diagnosis
No. of
nonirradiated
siblings
No. of
irradiated
siblings
1 Libya 3 0 0 1 4 8 3 1 69 1 1
2 Morocco 4 0 0 1 2 7 7 4 32, 37, 52, 54 2 1
3 Morocco 2 0 Lymphoma 0 5 8 5 2 35, 45 3 0
4 Morocco 3 Breast, leukaemia 0 2 3 10 5 1 49 2 2
5 Morocco 2 Leukaemia Mole 2 3 9 5 2 39, 42 2 1
6 Yemen 5 0 0 0 2 7 3 2 53, 55 1 0
7 Yemen 2 0 Lung 0 5 8 6 1 69 5 0
8 Morocco 2 Colon 0 1 3 7 3 2 40, 52 1 0
9 Morocco 3 Leukaemia Liver, leukaemia 1 4 11 1 1 54 0 0
10 Morocco 2 0 0 0 3 5 1 1 37 0 0
11 Morocco 3 0 0 0 5 8 8 3 45, 47, 51 5 0
12 Iraq 2 Breast, BCC Colon, lung, lung 3 2 12 6 2 42, 49 2 2
13 Iran 2 0 0 1 2 5 3 1 52 2 0
14 Morocco 2 BCC 0 2 4 9 4 2 46, 57 1 1
15 Iran 3 0 Breast 0 2 6 5 2 56, 56 3 0
Total 40 8 9 14 49 120 65 27 30 8
Abbreviations: BCC¼basal cell carcinoma; RAM¼radiation-associated meningioma. *One sample from family ID 4 was excluded because of call rate o95%.
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s(Horvath et al, 2004). FBAT is a generalised version of the classical
transmission–disequilibrium test, which can be applied to any
type of nuclear family (Laird et al, 2000), thus avoiding the issue of
population admixture that is a commonly encountered in case–
control study designs. In the FBAT programme, the additive model
was used.
Haplotype analyses were performed using sliding window sizes
of 12 contiguous markers. Haplotype frequencies for each
individual were estimated using an expectation-maximisation
(EM) algorithm. The minimum haplotype frequency was set at
0.01, and haplotypes with frequencies below this threshold were
combined into a single group.
Because of the large number of multiple tests performed, we used
the Benjamini and Hochberg correction (Benjamini et al, 2001) for
multiple testing, which is a method for controlling the false
discovery rate, to adjust the haplotypic P-values. This correction
consists of ranking all the P-values, from smallest to largest, and
adjusting each by multiplying by the total number of tests
and dividing by the rank of that P-value. All test statistics with
rank less than the test statistic with the largest rank for which
the corrected value is less than the desired error rate (e.g., 0.05)
are significant.
Mutational analysis
A search for mutations in the coding regions and splice sites of all
isoforms of CTNNA3 and LRRTM3, as annotated by GRChB37, was
performed by sequencing amplified PCR fragments using BigDye
Terminator chemistry implemented on an ABI 3730xl sequencer
(Applied Biosystems, Carlsbad, CA, USA). PCR primers were
designed using Primer 3 software and are given in Supplementary
Table 1. Sequence traces were aligned and compared with the gene
consensus sequence using Mutation Surveyor (Version 3.2; Soft-
Genetics, State College, PA, USA). Two in silico algorithms,
PolyPhen (http://genetics.bwh.harvard.edu/pph/) and SIFT (http://
sift.jcvi.org), were used to predict the putative impact of missense
variants on protein function. Scores were classified as tolerated,
borderline or deleterious according to the proposed criteria.
RESULTS
Illumina 610Quad SNP genotypes were obtained for all 66 samples
genotyped. Before conducting association-based analyses, we
subjected the SNP data set to rigorous quality control in terms
of excluding samples and SNPs with poor call rates. As mentioned
previously, one sample was excluded because of having a call rate
of o95%; the remaining samples had average call rates across all
SNPs of 499%. Thus, the final analysis was based on 65 samples.
Following this, we critically evaluated the data set for ancestral
differences by principal component analysis (Figure 1). Although
minor differences were apparent, all individuals genotyped were
relatively ancestrally comparable. Thus, without introducing
significant systematic bias we considered the data set to be
uniform to maximise power to detect important associations under
the assumption of homogeneity and an ancestral risk haplotype for
RAM. In all analyses we treated individuals with RAM as affected
and all other family members as of unknown phenotype.
The median distance between the 575272 autosomal SNPs in the
Illumina 610Quad arrays was B2.7Kb and B88% of the genome
was within 10Kb of a SNP marker. In this study, the heterozygosity
of markers was B94%, hence almost as many SNPs present on that
array are heterozygous in this Jewish population as in the general
Caucasian population.
We systematically interrogated haplotypes defined by a varying
number of SNPs. Haplotypes defined by 412 SNPs proved too
computationally intensive to recover on a genomewide basis. We
therefore restricted our search for disease-associated risk locus on
the basis of 12 SNP haplotypes.
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Figure 1 Principal component analysis of SNP genotypes showing the
extent of ethnic variability in the TC cohort. The first two principal
components of the analysis were plotted. HapMap CEU (Caucasian)
individuals are denoted by grey triangles, CHB (Chinese Han
Beijing)þJPT (Japanese in Tokyo) by grey diamonds, YRI (Yoruba) by
grey squares and TC cohort individuals are plotted in black.
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Figure 2 Manhattan plot of genomewide haplotype test P-values for the association between haplotypes and RAM. The –log10 P-values (y axis) are
presented at their chromosomal positions (x axis).
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sTable 2 Details of haplotypes showing evidence of association with RAM at Po0.001
Chr Start SNP End SNP Location P-value Enclosed gene(s)
2p25.3 rs10174217 rs13431590 2,742650–2761577 0.000317
4q35.2 rs4253236 rs925453 187148071–87179210 0.00022 KLKB1
7p14.3 rs1544470 rs12700916 28847869–28896396 0.000569 CREB5
7p14.1 rs2280668 rs7777684 39172024–39245404 0.000705 POU6F2
7p14.1 rs6949528 rs12701960 42261852–42314044 0.000726 GLI3
7p12.3 rs1025521 rs17662528 48492470–48508408 0.000487 ABCA13
8p23.2* rs2618841 rs10503179 2151954–2304545 0.000234
8p23.2* rs13259957 rs35909721 2304723–2324045 0.000731
8p23.2 rs11136914 rs7831044 5533388–5545090 0.000876
8q24.3 rs7822130 rs4076117 141242366–141247104 0.000964 TRAPPC9
9p21.1 rs10970796 rs10970826 32128828–32176938 0.000693
9p13.3 rs1571401 rs2812357 34572815–34655436 0.000574 CNTFR, C9orf23, DCTN3, ARID3C,
SIGMAR1, GALT, IL11RA,
9q21.12 rs10868893 rs2039646 73419560–73452088 0.000837 TRPM3
9q21.13* rs7851040 rs17095 75144401–75206337 0.00029 TMC1
9q21.13* rs7029452 rs17058062 75207329–75262770 0.000207 TMC1
10p11.22 rs703069 rs4747759 31933997–31974332 0.00066
10q11.21 rs11238782 rs4948591 44438863–44490414 0.00063
10q21.1 rs4935365 rs1343041 54629426–54665442 0.000566
10q21.1 rs10824952 rs4144618 54991869–55046704 0.000466
10q21.1 rs1930145 rs11004362 56286068–56302374 0.000813 PCDH15
10q21.1* rs2488843 rs2488827 57062207–57134988 0.00024 PCDH15
10q21.1* rs1777675 rs1334526 57139743–57183477 0.000921 PCDH15
10q21.1 rs1769039 rs714113 59953829–60061939 0.000361 IPMK, CISD1, ZCD1
10q21.2 rs10995111 rs2087625 64060268–64117756 0.000273 ZNF365
10q21.3 rs224285 rs10509173 64584810–64611889 0.000479
10q21.3 rs2619601 rs12357769 65461640–65520368 0.000171
10q21.3* rs7091769 rs7898508 66529552–66585513 0.000306
10q21.3* rs16920432 rs2932842 66586374–66662925 0.000604
10q21.3 rs17205485 rs953458 67057880–67082879 0.000712
10q21.3 rs1941993 rs4746538 67687416–67751473 0.000785 CTNNA3
10q21.3 rs1903863 rs10822705 67803410–67842734 0.000989 CTNNA3
10q21.3 rs2456750 rs1911323 68164444–68217760 0.000176 CTNNA3
10q21.3 rs1911343 rs997225 68257630–68282970 0.000156 CTNNA3
10q21.3 rs10997235 rs10822851 68324435–68361408 0.000186 CTNNA3
10q21.3 rs2394319 rs2394323 68794756–68827014 0.000645 CTNNA3, LRRTM3
10q21.3 rs7091927 rs10509284 68949597–69004536 0.000662 CTNNA3
10q21.3 rs16924708 rs932656 69380156–69530678 0.000628 CTNNA3
10q21.3 rs4558056 rs3740593 70401976–70501910 0.000514 TET1, CCAR1
10q22.1 rs1163179 rs1498325 70610209–70636836 0.000514 STOX1
11p13 rs11032695 rs2284369 34447586–34468936 0.000531 CAT
11p11.2 rs4755854 rs7123370 44649231–44694382 0.000362
14q24.2 rs193444 rs17178387 71817538–71997723 0.00092 SIPA1L1
14q32.12 rs4900155 rs4905002 93316522–93350376 0.000834
15q21.1 rs999128 rs1865649 47895214–47939505 0.000982 SEMA6D
15q21.3 rs958760 rs573740 54636344–54683431 0.000527 UNC13C, HO74
15q25.3 rs2346715 rs720736 87081060–87136204 0.000365 AGBL1
15q26.1 rs293380 rs1125105 89645230–89689964 0.000574 ABHD2
18q21.1 rs11662257 rs1878059 44204073–44234546 0.000673
18q21.1* rs4121690 rs2032215 44344852–44439011 0.000245 PIAS2
18q21.1* rs12454431 rs2576042 44451644–44577461 0.000075 PIAS2,KATNAL2,TCEB3CL/C/B,
DKfZp667C165
18q21.2** rs1364417 rs2286812 53693949–53717464 0.000405
18q21.2** rs17733784 rs764699 53719925–53745508 0.000491
18q21.31 rs967044 rs727453 53958845–54045333 0.000351
18q21.31 rs1942336 rs4077610 54778102–54843053 0.000185 FAM44C, BOD1P
18q21.31 rs644016 rs12967876 55164547–55191037 0.000627
18q21.31* rs2663862 rs8094024 55479671–55516213 0.000779
18q21.31* rs12966493 rs12953872 55517038–55580836 0.000028
18q21.32 rs4643439 rs4261640 56694779–56732513 0.000921
18q21.32* rs2271731 rs11660643 56826077–56852972 0.00056
18q21.32* rs7228554 rs9319943 56858758–56879827 0.000676
18q21.33 rs500424 rs495005 60540860–60597508 0.000727 PHLPP
18q21.33 rs1589593 rs8088231 61398078–61457669 0.000515 SERPINB7
18q22.3 rs7227719 rs8095198 69119371–69160768 0.000787
19q13.32 rs448784 rs8102349 48764721–48832554 0.000715 ZNF114, CCDC114, EMP3, DKFZp434D2472
21q22.11 rs13051785 rs2834315 35323286–35.355410 0.000731 CR626360
22q13.33 rs7290681 rs138220 50492235–50550808 0.000443 TTL8, MLC1, MOV10L1
Abbreviations: SNP¼single-nucleotide polymorphism; RAM¼radiation-associated meningioma. Chromosomal coordinates derived from the Genome Reference Consortium GRChB37.
*, **Denote haplotypes of length 12 that are consecutive.
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and 41414 haplotype tests across the genome (Figure 2). In all,
66 haplotype tests provided evidence for an association between
genotype and RAM at Po0.001 (Table 2) including multiple
haplotypes on chromosomes 18 and 10. The strongest associations
were shown at 18q21.1 (P¼7.5 10
 5), 18q21.32 (P¼2.8 10
 5)
and 10q21.3 (P¼1.6 10
 4).
A number of genes map to the 18q21.1 region of association
including PIAS2, KATNAL2, TCEB3CL, TCEB3C, TCEB3B and
DKfZp667C165, whereas the 18q21.31 region is bereft of genes. In
contrast to the other associations, the 10q21.3 signal was
characterised by a large number of neighbouring haplotype
associations; eight providing evidence for an association at
Po0.001. These haplotypes all mapped within a 2Mb region of
10q21.3 and all annotate the catenin (cadherin-associated protein),
a-3 (CTNNA3) gene. Among the top 66 associations, we identified
only two other genes that were annotated by multiple haplotype
tests showing evidence for an association at Po0.001. Specifically,
TMC1 on 9p21.13 and PCDH15 on 10q21.1 were captured two and
three times, respectively, by haplotype associations (Table 2).
The CTNNA3 is part of the Wnt signalling pathway and,
although speculative, CTNNA3 represents an attractive basis for
susceptibility given the role of dysfunctional Wnt signalling in
radiosensitivity. In view of this, we explored the possibility that a
common or restricted set of coding sequence changes in CTNNA3
might underscore the 10q21.3 association. For completeness we
also screened the leucine rich repeat transmembrane neuronal 3
(LRRTM3) gene that maps internally within CTNNA3 (Figure 3).
Nine sequence changes within coding sequence were identified in
the same 65 individuals whose DNA passed QC in the genomewide
stage. These included five polymorphic variants documented in
dbSNP (four in CTNNA3 and one in LRRTM3) and four novel
changes (three and one in CTNNA3 and LRRTM3, respectively).
Seven of the variants identified were missense changes, six in
CTNNA3 and one in LRRTM3. None of the missense changes identi
fied were confined to individuals with a RAM phenotype (Supple-
mentary Table 2). Furthermore, none of the sequence changes were
predicted to impact on the functionality of the expressed protein.
DISCUSSION
The TC cohort is unique, and has allowed us to recently assess the
impact of environmental and inherited risk factors on tumour
development in those exposed to ionising radiation (Bondy et al,
2008). In contrast to the rarity of familial meningioma in the general
population, 17 families within the TC study had two or more
members affected with RAM, equating to sibling relative risk of
B20-fold. As the doses of therapeutic radiation administered to
individuals within the TC cohort were similar (interquartile
range (25–75%) 127–153cGy), it has raised the possibility that the
impact of ionising radiation on cancer risk is in part a consequence
of genetic susceptibility conferred by low penetrance genes.
To provide evidence for this hypothesis and identify a RAM-
associated disease locus, we have conducted an associated analysis
using high-density SNP genotyping. The SNP LD mapping strategy
employed in this study has relied on the comparatively large
regions of LD that encompass founder mutations segregating in
the Jewish population. This simple study design strategy and using
DNAs from a small number of people has previously been
successfully used to localise a susceptibility gene for Bloom’s
syndrome (Mitra et al, 2004).
Predicated on the assumption of inherited predisposition, our
study provides insight into the possible architecture of genetic
susceptibility to RAM. Over a range of gene frequencies of 0.001 to
0.05, and stipulating a false positive rate of 0.0001, our study had
high power (470%) to identify a disease-associated haplotype
contributing 430% of the excess risk assuming a simple genetic
model of familial aggregation. Although assuming an effect size of
30% is high for many complex traits as previously articulated, an
assumption on which our study was predicated is that RAM is
primarily a consequence of major gene susceptibility and because
of the restricted ethnicity allelic heterogeneity is limited.
An alternative model of RAM is that this phenotype is a
consequence of a complex-polygenic basis. Failure to unambi-
guously identify a single locus is thus entirely compatible with the
latter model of disease susceptibility, whereby disease risk is
mediated by alleles conferring more modest effects, possibly
through the consequence of the co-inheritance of multiple low-risk
variants. Under this model, we would have had only very limited
power to identify a disease-causing locus, stipulating a P-value of
1 10
 6 to ensure genomewide significance. At the lower
significance threshold, our analysis does provide some evidence
to support the involvement of a number of genes in the aetiology
of RAM; specifically, the gene encoding CTNNA3 that is captured
by the 10q21.3 haplotypes. This gene is of specific interest as it is
part of the Wnt signalling pathway, which has been related to
cancer development and neurodegeneration. Several components
of the Wnt pathway have been implicated in carcinogenesis and
are best known to be involved in colorectal, lung, prostate, breast
and skin cancers (Behrens et al, 2009; Lai et al, 2009). Moreover
the CTNNA3 gene contains a fragile site of potential interest
in terms of genomic instability as there is evidence suggesting that
it may function as a tumour suppressor (Smith et al, 2006).
Although there is evidence for inherited susceptibility to
radiosensitivity outside the context of a restricted set of
syndromes, it is primarily derived from in vitro data. However,
the phenotype radiosensitivity is relatively prosaic, and establish-
ing a relationship between genotype and sensitivity is inherently
problematic as multiple clinical end points can be considered,
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smany of which are ill defined. To obviate this, we have made use of
a unique cohort and have sought to establish a relationship
between constitutional genotype and cancer risk.
Failure in our study to unambiguously identify a single high-risk
locus provides evidence for a model of inherited susceptibility to
radiosensitivity based on the co-inheritance of multiple low-risk
variants. Although individually such loci only confer small effects,
it is likely that they act multiplicatively, exerting relatively
profound effects in a small proportion of the population.
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